院前氨甲环酸与中重度创伤性脑损伤患者脑水肿的关联
本文为一项跨国院前氨甲环酸试验的回顾性分析,纳入108例中重度TBI且置入颅内压监测的患者(安慰剂组31例、1 g+1 g组38例、2 g弹丸组39例)。三组在年龄、性别、头部简明损伤定级、格拉斯哥昏迷评分、损伤严重度评分、首个24小时晶体液与血制品输注量、Marshall评分、颅内出血及死亡率方面均无差异。颅内压>20 mm Hg与脑灌注压<60 mm Hg的小时占比及去骨瓣减压率在三组间也无差异。作者认为这些结果对氨甲环酸可能影响脑水肿的假说提出疑问,鉴于本研究的探索性质与样本量有限,需进一步研究确认。
要点
- 回顾性分析108例中重度TBI置入颅内压监测者:安慰剂31例、1 g+1 g组38例、2 g弹丸组39例。
- 三组颅内压>20 mm Hg的小时占比无差异,脑灌注压<60 mm Hg的小时占比也无差异。
- 三组去骨瓣减压率相似,提示院前氨甲环酸未改变需去骨瓣减压的情况。
- 三组年龄、性别、头部简明损伤定级、格拉斯哥昏迷评分、损伤严重度评分、首个24小时晶体液与血制品、Marshall评分、颅内出血及死亡率均无差异。
- 作者认为结果对氨甲环酸潜在影响脑水肿提出疑问,因探索性质与样本量有限,需进一步研究确认。
适用人群与场景
- 中重度创伤性脑损伤患者,院前格拉斯哥昏迷评分<13且收缩压>90 mm Hg。
- 选自一项跨国院前氨甲环酸试验,并选取其中置入颅内压监测的患者进行分析。
诊断标准与关键阈值
- 院前格拉斯哥昏迷评分<13。
- 收缩压>90 mm Hg。
- 损伤后2小时内给药。
- 置入颅内压监测。
处置流程与药物剂量
- 随机分为安慰剂组、2 g氨甲环酸弹丸组、1 g氨甲环酸弹丸后1 g 8小时输注组,均为院前损伤后2小时内给药。
研究设计与关键结果
- 回顾性分析跨国院前氨甲环酸试验,共108例置入颅内压监测的中重度TBI患者:安慰剂组n=31,1 g+1 g组n=38,2 g弹丸组n=39。
- 三组年龄、性别、头部简明损伤定级、格拉斯哥昏迷评分、损伤严重度评分、首个24小时晶体液与血制品输注量、Marshall评分、颅内出血及死亡率均无差异。
- 三组颅内压>20 mm Hg的小时占比无差异,脑灌注压<60 mm Hg的小时占比无差异,去骨瓣减压率也相似。
证据类型、等级与局限
- 证据类型:对一项跨国院前氨甲环酸试验的回顾性分析。
- 证据等级:治疗/照护管理;Level IV。
- 局限:作者指出本研究为探索性质且样本量有限,需进一步研究确认。
对床旁实践的改变
- 作者认为,未发现氨甲环酸治疗与颅内压升高、脑灌注压降低或需去骨瓣减压之间的关联,这些结果对氨甲环酸潜在影响脑水肿的作用提出疑问。
- 作者指出,鉴于本研究的探索性质与样本量有限,需进一步研究确认该发现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic brain injury (TBI) contributes to substantial morbidity and mortality worldwide. Tranexamic acid (TXA) has been shown to reduce mortality in patients with traumatic intracranial hemorrhage (ICH) when given within 2 hours of injury. Although TXA is an antifibrinolytic, most studies have observed no difference in ICH progression; recent studies suggest that TXA may reduce cerebral edema in TBI. Our objective was to determine if prehospital TXA administered within 2 hours of injury is associated with surrogates of cerebral edema in patients with moderate or severe TBI.
METHODS: We performed a retrospective analysis of a multinational prehospital trial of TXA administered within 2 hours of injury in patients with moderate or severe TBI. Patients with prehospital Glasgow Coma Scale score of <13 and systolic blood pressure of >90 mm Hg were randomized to placebo, 2-g TXA bolus, or 1-g TXA bolus followed by 1 g 8-hour TXA infusion. Patients who received an intracranial pressure (ICP) monitor were selected for analysis. Baseline demographic, injury severity, and infusion characteristics were compared between TXA dosing cohorts. Proportion of hours spent with ICP of >20 mm Hg, cerebral perfusion pressure (CPP) of <60 mm Hg, and need for craniectomy were compared between groups.
RESULTS: A total of 108 patients with ICP monitors made up the study population (placebo, n = 31; 1 g + 1 g, n = 38; 2-g bolus, n = 39). No differences were identified in age, sex, Abbreviated Injury Scale head, Glasgow Coma Scale, Injury Severity Score, crystalloid and blood product infused in first 24 hours, Marshall score, ICH, or mortality between the three treatment arms. No differences in proportions of hours in which ICP of >20 mm Hg or CPP of <60 mm Hg were identified between treatment arms; rate of craniectomy was also similar.
CONCLUSION: No association could be identified between TXA treatment and ICP elevation, CPP depression, or need for craniectomy. These results question TXA's potential impact on cerebral edema. Further study is needed to confirm this finding based on the exploratory nature and limited number of subjects in this study.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- McKinley WI, Lazaridis C, Mansour A, et al. Association between prehospital tranexamic acid and cerebral edema in patients with moderate or severe traumatic brain injury. J Trauma Acute Care Surg. 2025. PMID: 39924682. doi:10.1097/TA.0000000000004516
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。